Palisade Bio to Participate at the Virtual Investor Ask the CEO Conference
October 11 2023 - 9:05AM
Palisade Bio (Nasdaq: PALI), a biopharmaceutical company
focused on developing novel therapeutics for serious chronic
gastrointestinal (GI) diseases, today announced that J.D. Finley,
Chief Executive Officer of Palisade Bio will participate at the
Virtual Investor Ask the CEO Conference on Wednesday, October 25,
2023 at 2:00 PM ET.
The "Ask the CEO" conference is intended to
provide the investment community with access to ask their questions
directly to management. Investors and interested parties will have
the opportunity to submit questions live during the event.
Questions can also be pre-submitted leading up to the event through
virtualinvestorco.com/asktheceo-pali. Participating companies will
answer as many questions as possible during the event.
A live video webcast of the presentation will be
available on the Events page of the Investors section of the
Company’s website (www.palisadebio.com). A webcast replay will be
available two hours following the live presentation and will be
accessible for 90 days.
About Palisade Bio
Palisade Bio is a biopharmaceutical company
focused on developing novel therapeutics for serious chronic
gastrointestinal diseases. The Company believes that by using a
targeted approach with its novel therapeutics it will transform the
treatment landscape. For more information, please go
to www.palisadebio.com.
Investor Relations ContactJTC Team, LLCJenene
Thomas 833-475-8247PALI@jtcir.com
Palisade Bio (NASDAQ:PALI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Palisade Bio (NASDAQ:PALI)
Historical Stock Chart
From Sep 2023 to Sep 2024